рус eng 中文 عربي esp por fra tgl msa
рус eng 中文 عربي esp por fra tgl msa

Press Releases

Press Releases
The number of Russians ready to be vaccinated against coronavirus has reached 42%, a FOM poll shows

Press release, 14.12.2020

AstraZeneca will test using component of Russia’s Sputnik V in clinical trials of its own vaccine against coronavirus

Press release, 11.12.2020

RDIF and Government of Argentina have signed a contract to supply 10 million doses of the Sputnik V vaccine

Press release, 10.12.2020

RDIF and Ministry of Health of Kazakhstan announce cooperation on the registration, production and distribution of the Sputnik V vaccine

Press release, 04.12.2020

RDIF and Hetero agree to produce over 100 million doses of the Sputnik V vaccine in India

Press release, 27.11.2020

The cost of one dose of the Sputnik V vaccine will be less than $10 for international markets

Press release, 24.11.2020

Second interim analysis of clinical trial data showed a 91.4% efficacy for the Sputnik V vaccine on day 28 after the first dose; vaccine efficacy is over 95% 42 days after the first dose

Press release, 24.11.2020

Russia is considered a highly trusted vaccine manufacturer and almost half of respondents in 11 countries are aware of Sputnik V, a YouGov poll shows

Press release, 17.11.2020

RDIF and GL Rapha (Hankook Korus) agree to produce over 150 million doses of the Sputnik V vaccine in South Korea

Press release, 13.11.2020

The first interim data analysis of the Sputnik V vaccine against COVID-19 phase III clinical trials in the Russian Federation demonstrated 92% efficacy

Press release, 11.11.2020

Message has been successfully sent!

Thank you!
You have been subscribed